James F. Young
President, MEDIMMUNE INC /DE.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 31, 2024Sold 5,400 shares at $8.00 of Novavax2
- Dec 24, 2024Sold 4,600 shares at $8.48 of Novavax2
- Jun 21, 2024Sold 7,500 shares at $14.09 of Novavax3
- Jun 18, 2024Sold 1,107 shares at $14.28 of Novavax4
- Jun 18, 2024Sold 6,393 shares at $13.62 of Novavax4
- Jun 12, 2024Exercised options 6,670 shares of Novavax5
- Jun 10, 2023Exercised options 4,600 shares of Novavax6
- Jun 17, 2022Exercised options 1,400 shares of Novavax7
- Mar 31, 2022Sold 300 shares at $75.10 of Novavax8
- Mar 31, 2022Sold 3,255 shares at $74.25 of Novavax8
- Mar 31, 2022Sold 8,945 shares at $73.29 of Novavax8
- Dec 31, 2021Sold 3,750 shares at $144.16 of Novavax9
- Dec 31, 2021Exercised options 3,750 shares at $25.60 of Novavax9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovavax, Board member
- 2
- 3SEC EDGARForm 4 filed Jun 25, 2024
- 4SEC EDGARForm 4 filed Jun 21, 2024
- 5SEC EDGARForm 4 filed Jun 14, 2024
- 6SEC EDGARForm 4 filed Jun 13, 2023
- 7SEC EDGARForm 4 filed Jun 21, 2022
- 8SEC EDGARForm 4 filed Apr 4, 2022
- 9SEC EDGARForm 4 filed Jan 4, 2022